+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Targeted Sequencing Market by Product Type (Instruments, Reagents & Kits, Software & Services), Platform (Amplicon Sequencing, Hybrid Capture, Molecular Inversion Probes), End User, Application - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Targeted Sequencing Market by Product Type (Instruments, Reagents & Kits, Software & Services), Platform (Amplicon Sequencing, Hybrid Capture, Molecular Inversion Probes), End User, Application - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Targeted Sequencing Market by Product Type (Instruments, Reagents & Kits, Software & Services), Platform (Amplicon Sequencing, Hybrid Capture, Molecular Inversion Probes), End User, Application - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924844
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Targeted Sequencing Market is undergoing significant evolution as advances in genomics, regulatory frameworks, and informatics converge to shape new opportunities for healthcare and research organizations globally. Senior decision-makers in diagnostics, pharma, and biotech face a dynamic competitive landscape demanding agility and strategic foresight.

Market Snapshot: Targeted Sequencing Market

The targeted sequencing market grew from USD 7.60 billion in 2024 to USD 9.18 billion in 2025 and is anticipated to accelerate at a CAGR of 20.07% to reach USD 22.78 billion by 2030. Expansion is being driven by swift adoption of advanced sequencing technologies, increasing demand for personalized medicine, and strategic responses to evolving regulatory and trade environments. Market participants are prioritizing modular, scalable solutions to serve segments from core labs to point-of-care environments, with particular advances in precision diagnostics and data-driven research in key geographic regions.

Scope & Segmentation Overview

This market research offers strategic analysis of the targeted sequencing landscape, structured to give actionable insights for leaders seeking growth and resilience amid shifting global dynamics.

  • Product Types: Instruments (Benchtop Sequencers, High-Throughput Sequencers), Reagents & Kits (Amplicon-Based Kits, Hybridization-Based Kits, MIP-Based Kits), Software & Services (Bioinformatics Services, Data Analysis Software)
  • Platform Approaches: Amplicon Sequencing (Multiplex PCR, UMI-Based Sequencing), Hybrid Capture (Baits-Based Capture, Probe-Based Capture), Molecular Inversion Probes (MIP Probes for CNV Analysis, SNP Detection)
  • End Users: Academic & Research Institutes (Private and Public Labs), Hospitals & Diagnostic Centers (Point-of-Care and Reference Labs), Pharmaceutical & Biotechnology Companies (Clinical Research Organizations, Drug Discovery Units)
  • Applications: Biomarker Discovery (Pharmacogenomic and Predictive Biomarkers), Genetic Diseases (Prenatal Testing, Rare Disease Diagnosis), Infectious Diseases (Antibiotic Resistance Testing, Pathogen Detection), Oncology (Diagnostics, Prognostics, Theranostics)
  • Geographical Coverage: Americas (US, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, Russia, UAE, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, Korea, Southeast Asia)
  • Leading Companies Analyzed: Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, F. Hoffmann-La Roche, BGI Genomics, Twist Bioscience, Pacific Biosciences, Oxford Nanopore, NeoGenomics

Key Takeaways for Senior Decision-Makers

  • Recent technological innovations in multiplex PCR, unique molecular identifiers, and hybrid capture have notably improved sensitivity and workflow efficiency within targeted sequencing.
  • Buyer demand for customizable panels and data-centric workflows continues to increase as stakeholders seek modular solutions and end-to-end integration for diverse clinical and research settings.
  • Regulatory frameworks are evolving, offering expedited pathways for companion diagnostics while emphasizing robust data privacy and quality control for next-generation sequencing applications.
  • The distinction between reagent kits and software-driven analytics is diminishing, underscoring the critical role of informatics in overall value creation and competitive positioning.
  • Strategic partnerships, mergers, and vertical integration among instrument manufacturers, reagent suppliers, and bioinformatics vendors are reshaping market structure and driving innovation.
  • Regional expansion strategies are being shaped by infrastructure maturity, regulatory readiness, and growing investment in genomics and precision medicine across the Americas, EMEA, and Asia-Pacific.

Tariff Impact on Supply Chains and Pricing

The implementation of the United States’ 2025 tariff schedule has introduced new pressures on supply chains and procurement within the targeted sequencing sector. Higher duty rates on select instruments and reagents are prompting manufacturers to reconsider sourcing and logistics, while distributors adjust pricing to reflect increased landed costs. In response, multinational providers are localizing production and leveraging regional trade agreements to retain market competitiveness. These shifts place a premium on agile supply chain strategies and proactive regulatory engagement, especially as end users weigh pricing decisions and total cost of ownership across procurement cycles.

Research Methodology & Data Sources

Insights in this report are grounded in a robust analytical process, including a literature review of peer-reviewed sources, patents, and industry white papers. In-depth expert interviews with leading stakeholders supplement this secondary research. Trusted proprietary databases, financial disclosures, and trade publications provided quantitative data, validated through triangulation and expert review, ensuring high confidence in findings.

Why This Report Matters

  • Supports strategic planning by providing a comprehensive assessment of market segmentation, competitive positioning, and technology trends in the targeted sequencing market.
  • Enables leaders to anticipate market shifts from regulatory and tariff impacts, inform resource allocation, and accelerate adoption of scalable sequencing solutions.
  • Empowers companies to align growth strategies with evolving customer needs and innovative applications in core geographic regions.

Conclusion

The targeted sequencing market is advancing through innovation, strategic alliances, and adaptive response to regulatory and trade developments. Stakeholders who leverage integrated solutions and proactive supply chain strategies will unlock new opportunities and build sustainable competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Targeted Sequencing Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Benchtop Sequencers
8.2.2. High-Throughput Sequencers
8.3. Reagents & Kits
8.3.1. Amplicon-Based Kits
8.3.2. Hybridization-Based Kits
8.3.3. MIP-Based Kits
8.4. Software & Services
8.4.1. Bioinformatics Services
8.4.2. Data Analysis Software
9. Targeted Sequencing Market, by Platform
9.1. Introduction
9.2. Amplicon Sequencing
9.2.1. Multiplex PCR
9.2.2. UMI-Based Sequencing
9.3. Hybrid Capture
9.3.1. Baits-Based Capture
9.3.2. Probe-Based Capture
9.4. Molecular Inversion Probes
9.4.1. MIP Probes For CNV Analysis
9.4.2. MIP Probes For SNP Detection
10. Targeted Sequencing Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Private Research Labs
10.2.2. Public Research Labs
10.3. Hospitals & Diagnostic Centers
10.3.1. Point-of-Care Laboratories
10.3.2. Reference Laboratories
10.4. Pharmaceutical & Biotechnology Companies
10.4.1. Clinical Research Organizations
10.4.2. Drug Discovery Units
11. Targeted Sequencing Market, by Application
11.1. Introduction
11.2. Biomarker Discovery
11.2.1. Pharmacogenomic Biomarkers
11.2.2. Predictive Biomarkers
11.3. Genetic Diseases
11.3.1. Prenatal Testing
11.3.2. Rare Disease Diagnosis
11.4. Infectious Diseases
11.4.1. Antibiotic Resistance Testing
11.4.2. Pathogen Detection
11.5. Oncology
11.5.1. Diagnostics
11.5.2. Prognostics
11.5.3. Theranostics
12. Americas Targeted Sequencing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Targeted Sequencing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Targeted Sequencing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Illumina, Inc.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Agilent Technologies, Inc.
15.3.4. QIAGEN N.V.
15.3.5. F. Hoffmann-La Roche Ltd
15.3.6. BGI Genomics Co., Ltd.
15.3.7. Twist Bioscience Corporation
15.3.8. Pacific Biosciences of California, Inc.
15.3.9. Oxford Nanopore Technologies plc
15.3.10. NeoGenomics, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. TARGETED SEQUENCING MARKET MULTI-CURRENCY
FIGURE 2. TARGETED SEQUENCING MARKET MULTI-LANGUAGE
FIGURE 3. TARGETED SEQUENCING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TARGETED SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. TARGETED SEQUENCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. TARGETED SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TARGETED SEQUENCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TARGETED SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON-BASED KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MIP-BASED KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY UMI-BASED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BAITS-BASED CAPTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PROBE-BASED CAPTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MIP PROBES FOR CNV ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MIP PROBES FOR SNP DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRIVATE RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PUBLIC RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY POINT-OF-CARE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACOGENOMIC BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY RARE DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ANTIBIOTIC RESISTANCE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PROGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY THERANOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 100. CANADA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. CANADA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 102. CANADA TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 103. CANADA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 104. CANADA TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 105. CANADA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 106. CANADA TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 107. CANADA TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 108. CANADA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. CANADA TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 110. CANADA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 111. CANADA TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 112. CANADA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. CANADA TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 114. CANADA TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 115. CANADA TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 116. CANADA TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 117. MEXICO TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. MEXICO TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 121. MEXICO TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 122. MEXICO TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 123. MEXICO TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 125. MEXICO TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. MEXICO TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 127. MEXICO TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 129. MEXICO TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. MEXICO TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 131. MEXICO TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 132. MEXICO TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 133. MEXICO TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 203. GERMANY TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. GERMANY TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 205. GERMANY TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 206. GERMANY TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 207. GERMANY TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 208. GERMANY TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 209. GERMANY TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 210. GERMANY TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 211. GERMANY TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. GERMANY TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 213. GERMANY TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 214. GERMANY TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 215. GERMANY TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. GERMANY TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 217. GERMANY TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 218. GERMANY TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 219. GERMANY TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 220. FRANCE TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. FRANCE TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 222. FRANCE TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 223. FRANCE TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 224. FRANCE TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 225. FRANCE TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 226. FRANCE TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 227. FRANCE TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 228. FRANCE TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. FRANCE TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 230. FRANCE TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 231. FRANCE TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 232. FRANCE TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. FRANCE TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 234. FRANCE TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 235. FRANCE TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 236. FRANCE TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 254. ITALY TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. ITALY TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 256. ITALY TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 257. ITALY TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 258. ITALY TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 259. ITALY TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 260. ITALY TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 261. ITALY TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 262. ITALY TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. ITALY TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 264. ITALY TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 265. ITALY TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 266. ITALY TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. ITALY TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 268. ITALY TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 269. ITALY TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 270. ITALY TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 271. SPAIN TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. SPAIN TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 273. SPAIN TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 274. SPAIN TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 275. SPAIN TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 276. SPAIN TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 277. SPAIN TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 278. SPAIN TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 279. SPAIN TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. SPAIN TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 281. SPAIN TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 282. SPAIN TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 283. SPAIN TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. SPAIN TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 285. SPAIN TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 286. SPAIN TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 287. SPAIN TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2030 (USD MILLION)
TABLE 320. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA TARGETED SEQUENCING MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Targeted Sequencing market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd
  • BGI Genomics Co., Ltd.
  • Twist Bioscience Corporation
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies plc
  • NeoGenomics, Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.78 Billion
Compound Annual Growth Rate20.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Targeted Sequencing and Resequencing - Global Strategic Business Report - Product Image

Targeted Sequencing and Resequencing - Global Strategic Business Report

  • Report
  • 468 Pages
  • Global
From
Targeted Sequencing And Resequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Targeted Sequencing And Resequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 187 Pages
  • Global
From
Genomic Biomarker Market by Product Type (Instruments, Reagents & Kits, Services), Technology (Mass Spectrometry, Microarray, Next-Generation Sequencing), Application, End User, Biomarker Type - Global Forecast 2025-2030 - Product Image

Genomic Biomarker Market by Product Type (Instruments, Reagents & Kits, Services), Technology (Mass Spectrometry, Microarray, Next-Generation Sequencing), Application, End User, Biomarker Type - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Product (NGS), By Workflow (Pre-sequencing), By Application, By Technology, By Type, By End Use, And Segment Forecasts, 2024 - 2030 - Product Image

Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Product (NGS), By Workflow (Pre-sequencing), By Application, By Technology, By Type, By End Use, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Gene Panel Market by Product Type (Custom Panels, Platform, Predesigned Panels), Technology (Microarray, Ngs, Pcr), Application, End User - Global Forecast 2025-2030 - Product Image

Gene Panel Market by Product Type (Custom Panels, Platform, Predesigned Panels), Technology (Microarray, Ngs, Pcr), Application, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From

About the Targeted Sequencing Market

Targeted sequencing is a type of genomics technology that focuses on specific regions of the genome. It is used to identify genetic variants associated with diseases, to detect mutations in cancer, and to study gene expression. Targeted sequencing is a cost-effective alternative to whole-genome sequencing, as it requires less sequencing and data analysis. It is also used in clinical diagnostics, drug discovery, and agricultural research. Targeted sequencing is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.